Compact synchrotron makes tumors visible

Key points
- Soft tissue disorders like tumors are very difficult to recognize using normal X-ray machines.
- Unlike classical X-ray tubes, a synchrotron generates highly focused, monochromatic X-rays.
- The phase contrast, dark field and absorption images made using the new technology have complementary properties.
- X-ray images have become an integral part of daily medical practice.
Soft tissue disorders like tumors are very difficult to recognize using normal X-ray machines. There is hardly any distinction between healthy tissue and tumors. Researchers at the Technische Universität München (TUM) have now developed a technology using a compact synchrotron source that measures not only X-ray absorption, but also phase shifts and scattering. Tissue that is hardly recognizable using traditional X-ray machines is now visible.
X-ray images have become an integral part of daily medical practice. Bones, for example, absorb large amounts of X-rays because of their high calcium content. This allows them to be differentiated from air-filled cavities like the lungs and surrounding soft tissue. However, because of their very similar absorption coefficients, soft tissue, organs and structures inside organs, like tumors, are hardly discernable from one another using the medical devices deployed in medicine today.
Now a group of scientists headed by Franz Pfeiffer, Professor of Biomedical Physics in the Physics Department Department and the Faculty of Medicine at TU München, have for the first time succeeded in making such soft tissue visible. The scientists used a new kind of X-ray source that was developed only a few years ago.
Compact synchrotron source
Unlike classical X-ray tubes, a synchrotron generates highly focused, monochromatic X-rays. The individual rays all have the same energy and wavelength. In the past, X-rays with these properties could only be generated in large particle accelerators, which have a circumference of at least one kilometer. The compact synchrotron, in contrast, has merely the size of a car and fits into a normal laboratory.
"Monochromatic radiation is much better suited for measuring other parameters, in addition to absorption," explains Elena Eggl, doctoral candidate at the Chair of Biomedical Physics. "This is because it does not lead to artifacts that deteriorate the image quality."
The scientists inserted an optical grating into the focused X-ray beam, allowing them to detect even tiniest phase shifts and scattering of the radiation in addition to the absorption of X-rays. The first phase contrast tomography image from a compact synchrotron source was successfully acquired.
Complementary information
The phase contrast, dark field and absorption images made using the new technology have complementary properties. Liquid in tissue that remains indiscernible and, thus, invisible using conventional X-ray tubes, suddenly comes to life. The greatly improved soft tissue contrast of the new X-ray technology could also help make tumors detectable earlier on and enable quick diagnoses - in medical emergencies, for example.
The clarity of the new technology becomes apparent when comparing white and brown fatty tissue. "In a mouse we were able to recognize not only heart, liver and other organs much better, but could even differentiate between brown and white body fat," says Eggl.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNo viral cause for breast cancer and brain tumors
A major study conducted at the Sahlgrenska Academy has now disproved theories of a viral cause for breast cancer and the brain tumour, glioblastoma. The study, which was based on over seven billion DNA sequences and…
9 October 2013
NewsA new view of brain tumors
In the battle against brain cancer, doctors now have a new weapon - a new imaging technology that will make brain surgery dramatically more accurate by allowing surgeons to distinguish - at a microscopic level - between…
6 September 2013
NewsAspirin tied to smaller lung and colon cancer tumors
Colon and lung cancer patients who regularly took low-dose aspirin before their diagnosis tended to have less advanced tumors, in a new study. Scientists already knew that aspirin was tied to a decreased risk of death…
18 August 2013






